Insider · CIK 0002041627
Jaime Xinos
Files at ACHV (ACHIEVE LIFE SCIENCES, INC.). First filing Sep 8, 2025, latest Sep 8, 2025.
Jaime Xinos files SEC Form 4 as officer at ACHV (ACHIEVE LIFE SCIENCES, INC.). Since Sep 8, 2025, Jaime Xinos has reported 0 open-market buys worth $0 and 1 open-market sell worth $58k, the latest filed on Sep 8, 2025.
A track record needs three past buys with six months of prices behind them; Jaime Xinos has 0, so none is measured yet.
The newest scored trade: sold $58k of ACHV on Sep 4, 2025, filed Sep 8, 2025, scored 27 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ACHV: ACHIEVE LIFE SCIENCES, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | ACHIEVE LIFE SCIENCES, INC. | $58k 20,854 shares | -22% | +41% from low-47% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | ACHV ACHIEVE LIFE SCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +180,000 | $0.00 | $0 | 180,000 | Jan 30, 2026 |
| Sep 4, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | MOption exercise Common Stock | +69,000 | $0.00 | $0 | 95,286 | Sep 8, 2025 |
| Sep 4, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | SOpen-market sale Common Stock | -20,854 | $2.77 | $58k | 74,432 | Sep 8, 2025 |
| Sep 4, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | MOption exercise Performance Restricted Stock Unit (PRSU)derivative | -49,000 | $0.00 | $0 | 0 | Sep 8, 2025 |
| Sep 4, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | MOption exercise Performance Restricted Stock Unit (PRSU)derivative | -20,000 | $0.00 | $0 | 80,000 | Sep 8, 2025 |
| Jan 28, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | AGrant or award Performance Restricted Stock Unit (PRSU)derivative | +100,000 | $0.00 | $0 | 100,000 | Jan 30, 2025 |
| Jan 13, 2025 | ACHV ACHIEVE LIFE SCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jan 14, 2025 |
| Dec 6, 2024 | ACHV ACHIEVE LIFE SCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Dec 9, 2024 |
Questions about Jaime Xinos
Answered from the filings on this page, as of the latest one.
Is Jaime Xinos buying or selling?
Not in the last 12 months. Jaime Xinos's latest open-market trade on SEC Form 4 was sold $58k of ACHV on Sep 4, 2025.
How did Jaime Xinos's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jaime Xinos has 0.
Where does Jaime Xinos file Form 4?
Jaime Xinos has filed Form 4 at ACHV (ACHIEVE LIFE SCIENCES, INC.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.